via IU School of Medicine
Worldwide, 1 in 4 people will suffer from a depressive episode in their lifetime
While current diagnosis and treatment approaches are largely trial and error, a breakthrough study by Indiana University School of Medicine researchers sheds new light on the biological basis of mood disorders, and offers a promising blood test aimed at a precision medicine approach to treatment.
Led by Alexander B. Niculescu, MD, PhD, Professor of Psychiatry at IU School of Medicine, the study was published today in the high impact journal Molecular Psychiatry. The work builds on previous research conducted by Niculescu and his colleagues into blood biomarkers that track suicidality as well as pain, post-traumatic stress disorder and Alzheimer’s disease.
“We have pioneered the area of precision medicine in psychiatry over the last two decades, particularly over the last 10 years. This study represents a current state-of-the-art outcome of our efforts,” said Niculescu. “This is part of our effort to bring psychiatry from the 19th century into the 21st century. To help it become like other contemporary fields such as oncology. Ultimately, the mission is to save and improve lives.”
The team’s work describes the development of a blood test, composed of RNA biomarkers, that can distinguish how severe a patient’s depression is, the risk of them developing severe depression in the future, and the risk of future bipolar disorder (manic-depressive illness). The test also informs tailored medication choices for patients.
This comprehensive study took place over four years, with over 300 participants recruited primarily from the patient population at the Richard L. Roudebush VA Medical Center in Indianapolis. The team used a careful four-step approach of discovery, prioritization, validation and testing.
First, the participants were followed over time, with researchers observing them in both high and low mood states—each time recording what changed in terms of the biological markers (biomarkers) in their blood between the two states.
Next, Niculescu’s team utilized large databases developed from all previous studies in the field, to cross-validate and prioritize their findings. From here, researchers validated the top 26 candidate biomarkers in independent cohorts of clinically severe people with depression or mania. Last, the biomarkers were tested in additional independent cohorts to determine how strong they were at predicting who is ill, and who will become ill in the future.
From this approach, researchers were then able to demonstrate how to match patients with medications—even finding a new potential medication to treat depression.
“Through this work, we wanted to develop blood tests for depression and for bipolar disorder, to distinguish between the two, and to match people to the right treatments,” said Niculescu. “Blood biomarkers are emerging as important tools in disorders where subjective self-report by an individual, or a clinical impression of a health care professional, are not always reliable. These blood tests can open the door to precise, personalized matching with medications, and objective monitoring of response to treatment.”
In addition to the diagnostic and therapeutic advances discovered in their latest study, Niculescu’s team found that mood disorders are underlined by circadian clock genes—the genes that regulate seasonal, day-night and sleep-wake cycles.
“That explains why some patients get worse with seasonal changes, and the sleep alterations that occur in mood disorders,” said Niculescu.
According to Niculescu, the work done by his team has opened the door for their findings to be translated into clinical practice, as well as help with new drug development.
Focusing on collaboration with pharmaceutical companies and other doctors in a push to start applying some of their tools and discoveries in real-world scenarios, Niculescu said he believes the work being done by his team is vital in improving the quality of life for countless patients.
“Blood biomarkers offer real-world clinical practice advantages. The brain cannot be easily biopsied in live individuals, so we’ve worked hard over the years to identify blood biomarkers for neuropsychiatric disorders,” said Niculescu. “Given the fact that 1 in 4 people will have a clinical mood disorder episode in their lifetime, the need for and importance of efforts such as ours cannot be overstated.”
More from: Indiana University School of Medicine
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Feelings of isolation, depression rise in colder months
"It is a form of depression that's related to lack of exposure to sunlight, colder weather, longer, darker nights, just a general feeling of sadness," he said. "People tend to sleep more or want to ...
- Coronavirus-induced depression, anxiety disorders a threat to Vietnam’s public health
Vietnam is witnessing a surge in symptoms of anxiety and depression amid the COVID-19 pandemic, a trend that is putting the country’s healthcare workers, among other demographics, in harm’s way.
- Businesses seek to support employees struggling with depression, anxiety
Business and health leaders address the pandemic-induced mental health crisis and talked about ways to encourage employees to get vaccinated.
- Pregnant women experiencing depression focus of VCU study
A new clinical trial at VCU aims to study the impact of mindfulness activities and social connectedness on people experiencing depression while pregnant.
- Mushroom consumption may lower risk of depression
Mushrooms have been making headlines due to their many health advantages. Not only do they lower one's risk of cancer and premature death, but new research led by Penn State College of Medicine also ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Mesa police need help finding a missing autistic and bipolar boy
Police said the 11-year-old is diagnosed with autism and bipolar disorder. He's been missing since noon. He is a Black boy with brown eyes, brown hair, 5 feet five inches tall, weighs 145 pounds and ...
- Are bipolar brains filled with huge creative potential, or are they fragile, unstable, and hurt your feet when you step on them?
Let’s face it, bipolar is not such a popular condition. It’s strange and complex to some people. If you have it you can be sure that some people assume you’re broken, that it’s your fault, and that ...
- Lucknow: Bipolar disorder in kids alters brain, says study
For a long time, researchers pondered if there is any impact of bipolar disorder on various regions of the brain and brain development in children, bu ...
- Diet may help alleviate some symptoms of bipolar disorder
A study found that decreasing omega-6 fatty acid intake and increasing omega-3 fatty acid consumption helped stabilize mood in people with bipolar disorder.
- College Prep for Students with Bipolar
A successful student newly diagnosed with bipolar, I was initially unprepared for the transition to college. Here’s what can help you prepare for this ...